Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Nov-13 5:49 PM View:  | Silver Point Capital L.P. 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 18-Nov-13 | Purchase | 25,000 | $46.50 | $1,162,500.00 | 1% 2.0M to 2.02M | |
| 15-Nov-13 9:00 PM View: | Silver Point Capital L.P. 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 14-Nov-13 | Purchase | 50,000 | $44.50 | $2,225,000.00 | 3% 1.95M to 2.0M | |
| 15-Nov-13 9:00 PM View: | Silver Point Capital L.P. 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 13-Nov-13 | Purchase | 57,162 | $42.75 | $2,443,680.00 | 3% 1.89M to 1.95M | |
| 27-Sep-13 2:00 PM View: | Silver Point Capital L.P. 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 26-Sep-13 | Sale | 199,000 | $40.00 | $7,960,000.00 | (12%) 1.72M to 1.52M | |
| 25-Sep-13 5:36 PM View: | Silver Point Capital L.P. 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 23-Sep-13 | Purchase | 150,000 | $40.00 | $6,000,000.00 | 10% 1.57M to 1.72M | |
| 26-Sep-13 1:09 PM View: | Hermelin David S Director | KV Pharmaceutical Co. (KVA/KVB) | 16-Sep-13 | Disposition (other) | 68,250 | -- | -- | (2%) 3.55M to 3.48M | |
| 18-Sep-13 8:34 PM View: | Divis Greg J CEO and President Director | KV Pharmaceutical Co. (KVA/KVB) | 16-Sep-13 | Disposition (other) | 1,225 | -- | -- | (100%) 1.23K to 0 | |
| 26-Sep-13 1:09 PM View: | Hermelin David S Director | KV Pharmaceutical Co. (KVA/KVB) | 16-Sep-13 | Disposition (other) | 3,479,740 | -- | -- | (100%) 3.48M to 0 | |
| 20-Sep-13 12:48 PM View: | Sidransky David Director | KV Pharmaceutical Co. (KVA/KVB) | 16-Sep-13 | Disposition (other) | 1,000 | -- | -- | (100%) 1.0K to 0 | |
| 26-Sep-13 2:46 PM View: | Bentley Gregory Smith Director | KV Pharmaceutical Co. (KVA/KVB) | 16-Sep-13 | Disposition (other) | 10 | -- | -- | (100%) 10 to 0 | |
| 19-Sep-13 1:52 PM View: | Lehrer Joseph D Director | KV Pharmaceutical Co. (KVA/KVB) | 16-Sep-13 | Disposition (other) | 100 | -- | -- | (100%) 100 to 0 | |
| 07-Aug-13 6:02 AM View: | Glenview Capital Management... 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 06-Aug-13 | Market Purchase | 1,764,710 | $0.46 | $820,413.00 | (26%) 6.66M to 4.9M | 46% |
| 05-Aug-13 4:11 PM View: | Glenview Capital Management... 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 02-Aug-13 | Market Purchase | 703,000 | $0.55 | $386,650.00 | 12% 5.96M to 6.66M | 13% |
| 05-Aug-13 4:11 PM View: | Glenview Capital Management... 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 01-Aug-13 | Market Purchase | 800,000 | $0.58 | $464,000.00 | 16% 5.16M to 5.96M | 6% |
| 07-Feb-13 12:15 PM View: | Parkside Financial Bank & T... 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 29-Jan-13 | Conversion | 1,402,140 | -- | -- | 100% 1.4M to 2.8M | |
| 07-Feb-13 12:15 PM View: | Parkside Financial Bank & T... 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 29-Jan-13 | Conversion | 1,402,140 | -- | -- | (50%) 2.8M to 1.4M | |
| 08-Mar-11 2:50 PM View: | Hermelin Arnold L 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 04-Mar-11 | Market Sale | 100,000 | $10.24 | $1,023,560.00 | (26%) 389.18K to 289.18K | 99% |
| 17-Feb-11 1:55 PM View: | Parkside Financial Bank & T... 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 11-Feb-11 | Disposition (other) | 120,000 | -- | -- | (14%) 881.53K to 761.53K | |
| 08-Feb-11 6:56 PM View: | Parkside Financial Bank & T... 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 07-Feb-11 | Disposition (other) | 192,900 | -- | -- | (8%) 2.48M to 2.28M | |
| 08-Feb-11 6:56 PM View: | Parkside Financial Bank & T... 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 04-Feb-11 | Conversion | 832,000 | -- | -- | 32% 2.6M to 3.43M | |
| 08-Feb-11 6:56 PM View: | Parkside Financial Bank & T... 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 04-Feb-11 | Market Sale | 125,000 | $3.81 | $476,838.00 | (5%) 2.6M to 2.48M | 98% |
| 08-Feb-11 6:56 PM View: | Parkside Financial Bank & T... 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 04-Feb-11 | Conversion | 832,000 | -- | -- | (24%) 3.43M to 2.6M | |
| 17-Nov-10 6:14 PM View: | Hermelin Marc S 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 15-Nov-10 | Disposition (other) | 3,166,180 | -- | -- | (100%) 3.17M to 0 | |
| 13-Oct-10 6:21 PM View: | Hermelin Marc S Director 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 12-Oct-10 | Disposition (other) | 82,640 | -- | -- | (3%) 2.52M to 2.44M | |
| 30-Sep-10 3:55 PM View: | Hermelin Marc S Director 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 16-Sep-10 | Gift | 104,348 | -- | -- | (4%) 2.62M to 2.52M | |
| 12-Aug-10 10:37 AM View: | Baldini Robert E Director | KV Pharmaceutical Co. (KVA/KVB) | 05-Aug-10 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
| 08-Jul-10 4:02 PM View: | Sidransky David Director | KV Pharmaceutical Co. (KVA/KVB) | 02-Jul-10 | Grant | 7,500 | -- | -- | 750% 1.0K to 8.5K | |
| 12-Jul-10 8:10 AM View: | Stancic Ana Director | KV Pharmaceutical Co. (KVA/KVB) | 24-Jun-10 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
| 14-Jun-10 8:06 PM View: | Sampson John R. Director | KV Pharmaceutical Co. (KVA/KVB) | 10-Jun-10 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
| 14-Jun-10 7:27 PM View: | Bentley Gregory Smith Senior VP - Law Director | KV Pharmaceutical Co. (KVA/KVB) | 10-Jun-10 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
| 14-Jun-10 7:26 PM View: | Lehrer Joseph D Director | KV Pharmaceutical Co. (KVA/KVB) | 10-Jun-10 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
| 16-Jun-10 1:39 PM View: | Dow Mark A. Director | KV Pharmaceutical Co. (KVA/KVB) | 10-Jun-10 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
| 20-Jan-10 1:28 PM View: | Forsyth Janice C. VP, Gen. Counsel & Secretary | KV Pharmaceutical Co. (KVA/KVB) | 11-Jan-10 | Grant | 40,000 | -- | -- | 100% 0 to 40.0K | |
| 23-Nov-09 3:21 PM View: | Hermelin Marc S Director 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 19-Nov-09 | txn.W.title | 18,631 | -- | -- | < 1% 6.0M to 6.02M | |
| 02-Feb-09 2:40 PM View: | Hermelin Marc S Director 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 29-Jan-09 | Disposition (other) | 3,028,390 | -- | -- | (26%) 11.57M to 8.55M | |
| 23-Jan-09 5:04 PM View: | Hermelin Marc S Director 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 21-Jan-09 | Disposition (other) | 286,690 | -- | -- | (10%) 2.98M to 2.69M | |
| 25-Nov-08 5:05 PM View: | Hermelin Marc S Chairman & CEO Director 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 20-Nov-08 | Disposition (other) | 45,671 | -- | -- | (4%) 1.08M to 1.03M | |
| 14-Nov-08 4:12 PM View: | Chibnall Richard H Vice President/Finance | KV Pharmaceutical Co. (KVA/KVB) | 13-Nov-08 | Market Sale | 28,000 | $5.00 | $140,042.00 | (87%) 32.35K to 4.35K | 98% |
| 22-Sep-08 7:11 PM View: | Hermelin Marc S Chairman & CEO Director 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 18-Sep-08 | Disposition (other) | 467,326 | -- | -- | (16%) 2.99M to 2.53M | |
| 22-Sep-08 7:11 PM View: | Hermelin Marc S Chairman & CEO Director 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 18-Sep-08 | Acquisition (other) | 233,663 | -- | -- | 8% 2.76M to 2.99M | |
| 05-Sep-08 5:18 PM View: | Hermelin Marc S Chairman & CEO Director 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 03-Sep-08 | Disposition (other) | 148,000 | -- | -- | (2%) 7.61M to 7.46M | |
| 05-Sep-08 5:18 PM View: | Hermelin Marc S Chairman & CEO Director 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 03-Sep-08 | Acquisition (other) | 148,000 | -- | -- | 2% 7.46M to 7.61M | |
| 05-Sep-08 5:18 PM View: | Hermelin Marc S Chairman & CEO Director 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 03-Sep-08 | Disposition (other) | 70 | -- | -- | (< 1%) 7.46M to 7.46M | |
| 05-Sep-08 5:18 PM View: | Hermelin Marc S Chairman & CEO Director 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 03-Sep-08 | Acquisition (other) | 70 | -- | -- | < 1% 7.61M to 7.61M | |
| 21-Jul-08 11:20 AM View: | Divis Greg J President, Ther-Rx Corporation | KV Pharmaceutical Co. (KVA/KVB) | 18-Jul-08 | Option Exercise | 1,225 | $28.60 | $35,035.00 | 100% 0 to 1.23K | (29%) |
| 18-Jul-08 5:27 PM View: | Hermelin Marc S Chairman & CEO Director 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 16-Jul-08 | Disposition (other) | 800,000 | -- | -- | (12%) 6.82M to 6.02M | |
| 18-Jul-08 5:27 PM View: | Hermelin Marc S Chairman & CEO Director 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 16-Jul-08 | Acquisition (other) | 800,000 | -- | -- | 13% 6.02M to 6.82M | |
| 27-Jun-08 5:36 PM View: | Hermelin Marc S Chairman & CEO Director 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 25-Jun-08 | Disposition (other) | 233,663 | -- | -- | (44%) 535.13K to 301.46K | |
| 01-Apr-08 5:39 PM View: | Carlie Kevin S Director | KV Pharmaceutical Co. (KVA/KVB) | 31-Mar-08 | Option Exercise | 450 | $19.37 | $8,716.50 | 3% 13.05K to 13.5K | 29% |
| 25-Jan-08 5:06 PM View: | Hermelin Marc S Chairman & CEO Director 10% Owner | KV Pharmaceutical Co. (KVA/KVB) | 23-Jan-08 | Disposition (other) | 35,256 | -- | -- | (3%) 1.27M to 1.24M |
